tirzepatide molecular structure CID 163285897 | C225H348N48O68 | CID 163285897 Tirzepatide (LY-3298176) | GIP/GLP-1 agonist

Explore the potential connection between Ozempic and breast cancer, current research, and important considerations for diabetes management.

Gamma-Glutamyltransferase (GGT)

Since tirzepatide is a dual GLP1R/GIPR agonist, the interpretation is compelling: GIP receptor activation normally buffers the nausea-inducing effects of GLP-1 agonism, and when that buffer is genetically impaired, the GLP-1 component goes unchecked

This retrospective cohort study evaluated changes in time in therapeutic range (TTR) among patients receiving warfarin during the 6 months before and after GLP-1 RA initiation, using real-world data from the TriNetX Research Network

And for the last two years, one drug class has quietly started eating the entire wellness market alive - GLP-1

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats of the blockbuster drugs.